Skip to content
healthcare.dev

Montelukast Sodium

NDC 57237-255, Montelukast Sodium, tablet, film coated, from Rising Pharma Holdings, Inc..

Product NDC
57237-255
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202468
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/57237-255 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MONTELUKAST SODIUM10 mg/1

Pharmacologic classes

Leukotriene Receptor Antagonist [EPC]; Leukotriene Receptor Antagonists [MoA]

Package NDCNDC-11Package
57237-255-305723702553030 TABLET, FILM COATED in 1 BOTTLE (57237-255-30)
57237-255-905723702559090 TABLET, FILM COATED in 1 BOTTLE (57237-255-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/49669ac0-0bb5-4576-bed5-9e85e0d76a44

Use it

Look up 57237-255 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/57237-255 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 57237-255. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.